Introduction {#sec1_1}
============

An estimated 13.0s% of US adolescents are currently morbidly obese; a number that has impressively tripled over the past decade \[[@B1]\]. Obesity is associated with chronic health conditions including type 2 diabetes mellitus, hypertension, dyslipidemia, obstructive sleep apnea syndrome, and osteoarthritis \[[@B2],[@B3]\]. Furthermore, obese adolescents are likely to suffer from psychological morbidity, loss of self-esteem, and social exclusion \[[@B4]\]. Management of adolescent obesity is mostly focused at combined lifestyle intervention, initiated and coordinated by specialized pediatricians. While often effective in the short term, long-term effects are disappointing, especially in extreme obesity. A Cochrane review published in 2009 shows a maximum of 1.7 kg/m^2^ BMI loss after 12 months \[[@B5]\].

Bariatric surgery is becoming an accepted treatment for weight reduction in morbidly obese adolescents. Presently, three operative techniques are commonly used: laparoscopic adjustable gastric banding (LAGB), Roux-en-Y gastric bypass (RYGB), and laparoscopic sleeve gastrectomy. These techniques differ in excess weight loss, resolution of co-morbidity, quality of life improvement, and complication rate \[[@B6]\]. The short-term results are relatively well documented, but medium and long-term effects are largely unknown while studies in adults show that reoperation mostly occurs several years after bariatric surgery \[[@B7]\]. In our hospital LAGB was done in adolescents until 2008, when the Health Care Inspectorate (Inspectie voor de Gezondheidszorg; IGZ), based on a new national guideline on obesity, asked for more evidence-based practice and prohibited adolescent bariatric surgery. To assess the medium-term results of LAGB we analyzed the outcome of 10 adolescents who underwent this procedure more than 5 years ago.

The aim of this study is to assess long-term weight loss, adverse events, comorbidity resolution, and health status in morbidly obese adolescents operated on before 2008. The secondary aim is to evaluate the available data on eating behavior and personality traits before and after surgery \[[@B8],[@B9],[@B10],[@B11]\].

Material and Methods {#sec1_2}
====================

The hospital registration system was queried for all patients aged 18 years or younger who had surgery coded as LAGB. All patients were operated in or before 2008, when the IGZ prohibited bariatric surgery in adolescents in non-research settings. The medical ethics committee of the Maastricht University Medical Center waived the acquisition of informed consent (METC 14-4-122).

Patients were eligible for surgery if non-surgical attempts to lose weight had failed and BMI was above 40 kg/m^2^ or above 35 kg/m^2^ with comorbidity. The procedure was not scheduled before the patient had been assessed by a medical psychologist, primed for the postoperative eating pattern by a dietician and discussed in the multidisciplinary team. The adjustable silicone gastric band (Lap-Band, INAMED Health, Santa Barbara, CA, USA) was placed via laparoscopy using pars flaccida technique in all subjects \[[@B12]\].

Bariatric surgery follow-up included frequent outpatient clinic visits in the first year after surgery and yearly afterwards. Weight loss, vital parameters, comorbidity resolution, and adverse events were evaluated at each visit. The surgeon and dietician evaluated eating pattern and weight loss, and the gastric band was adjusted when indicated. In the past year, all adolescent patients were asked to complete questionnaires to assess their health status, eating behavior, and personality. Data on weight loss, comorbidity, and complications were retrospectively collected from medical records. Weight loss is expressed as BMI loss and as excess BMI loss (a normal BMI corresponds to the age- and sex-adjusted equivalent of 25 kg/m^2^) at the latest follow-up with gastric band in situ.

Questionnaires {#sec2_1}
--------------

Four validated questionnaires were used to assess health status, eating behavior and personality. The Dutch version of the Short Form 36 Health Survey (SF-36) was used to assess health status in eight domains. Raw scale scores of the SF-36 were transformed into standardized scores from 0 (the worst) to 100 (optimal) and compared to Dutch population reference values \[[@B13]\]. The Dutch Questionnaire of Eating Behavior (NVE) assesses eating behavior in three subscales: restrained eating, emotional eating, and external eating \[[@B14]\]. Subscale scores are compared to a Dutch normal-weight population in the graph \[[@B8]\]. The Eating Disorder Examination Questionnaire (EDE-Q) is a 36-item questionnaire to assess the psychopathology associated with the diagnosis of an eating disorder. It retains four subscales: restraint, eating concern, shape concern, and weight concern. Subscale sores are compared to international population references \[[@B15]\]. The Dutch Personality Questionnaire (NPV) assesses personality traits on seven scales: neuroticism, social anxiety, rigidity, hostility, egoism, dominance, and self-esteem \[[@B16]\]. Because the NPV is not validated under the age of 16 years, the junior version of the NPV (the NPV-J) was used for those who were younger in preoperative screening. It consists of five scales (of which three are identical to the scales on the adult version): neuroticism, perseverance, social anxiety, recalcitrance, and dominance \[[@B17]\]. All questionnaires, except for the SF-36, were also used during the preoperative screening.

Statistical Analysis {#sec2_2}
--------------------

Statistical analysis was performed using Prism 6.0 (GraphPad Software, Inc. La Jolla, CA, USA) and SPSS 19.0 (IBM Corporation, Somers, NY, USA). Baseline data were compared with data acquired at the latest visit with the gastric band in situ or with data acquired at the last visit, when appropriate. When patients were lost to follow-up, their last known data were used as end of follow-up. Weight assessment parameters and questionnaire scores are reported as median (interquartile range, IQR). Data were tested with non-parametric Wilcoxon signed rank test, since Gaussian distribution cannot be assumed and missing data at 6 and 12 months impedes multiple comparisons. A p value \< 0.05 was considered statistically significant.

Results {#sec1_3}
=======

Weight Loss, Adverse Events, and Reoperations {#sec2_3}
---------------------------------------------

Ten adolescents were treated with gastric banding between July 2004 and August 2008. Seven patients visited our clinic in the past year, while the other 3 were lost to follow-up. The presented results represent all 10 patients at their latest follow-up visit. BMI loss with gastric band in situ was 10.7 kg/m^2^ (−0.9 to 12.9 kg/m^2^) after a median follow-up of 64 months (52--84 months), corresponding to 63.7s% (−1.6 to 84.5s%) excess BMI loss (table [1](#T1){ref-type="table"}, fig. [1](#F1){ref-type="fig"}). Six patients lost more than 50s% excess BMI, one lost 41s%, and one lost 7s% while 2 patients gained weight despite their gastric band (43s% and 27s% excess BMI, respectively).

Individual adverse events and re-operations are listed in table [1](#T1){ref-type="table"}. Two subjects needed temporary desufflation of the gastric band; one for slippage and one for obstruction (after 2 and 3 years, respectively), after which their complaints resolved. In 4 out of 10 patients the band was removed.

One patient was treated in another bariatric surgery center for persistent referred pain in her left shoulder that resolved with removal of the gastric band. Conversion to biliopancreatic diversion (BPD) 3.5 years afterwards, because of weight regain, was uncomplicated and resulted in loss of 114s% of her previous excess BMI. Two years after conversion to BPD this patient was hospitalized for inflammatory disease of the colon with unknown etiology.

A second patient had unexplained persistent sensations of dyspnea from postoperative day 1 that resolved with removal of the band 4.5 years later. She regained 10 of the 40 kg she had lost before, but had a stable weight without further intervention at the last visit, more than 1 year after band removal. A third patient regained 20 of the 35 kg she had lost before, when she underwent uncomplicated conversion to RYGB after 3.5 years and lost exactly 100s% of her previous excess BMI. One year later she had an internal hernia that required laparoscopic repair (and revision 1 year later).

The fourth patient had her gastric band removed after 5.5 years because of weight regain and is now waiting for RYGB.

Other surgical procedures included: mammoplasty in 2 males and 1 female (combined with lower body lift) and an incisional hernia after BPD. One male patient is currently consulting a plastic surgeon for mammoplasty and lower body lift.

Comorbidity {#sec2_4}
-----------

Existing preoperative comorbidity was mostly limited to musculoskeletal complaints (of the back and lower extremities) and asthma. Table [2](#T2){ref-type="table"} demonstrates the diagnosed comorbidities and outcome at the end of follow-up. Diabetes and dyslipidemia did not occur while hypertension in two subjects resolved with weight loss.

Questionnaires {#sec2_5}
--------------

Three patients were not willing to visit our clinic for follow-up in the last year and were therefore unable to complete any questionnaires. The results of the remaining 7 patients and the baseline results are presented below.

Reported Health Status {#sec2_6}
----------------------

Figure [2](#F2){ref-type="fig"} represents the scores on the subscales of the SF-36 health status questionnaire with Dutch population references. The median score is within the mean ± 1 SD reference for all factors, but two subjects consistently score below the −1 SD reference on 5 or 6 subscales. Both low-scorers are male, still have a gastric band, and lost 59 and 92s% excess BMI, respectively. All but 1 patient, including these 2, reported that they would have opted for LAGB at this young age again.

Eating Behavior {#sec2_7}
---------------

Preoperative EDE-Q was available in 8 and NVE in 9 patients. Six patients had completed the questionnaires both before and after the procedure. There were no statistically significant differences in any of the subscales (fig. [3](#F3){ref-type="fig"}). Patients score particularly high on the weight and shape concern scales of the EDE-Q when compared to norm scores for a normal-weight population. Although weight concern on the EDE-Q shows the most substantial decrease, the change did not reach statistical significance (p = 0.07).

Personality Traits {#sec2_8}
------------------

Three patients completed the NPV at preoperative screening, while 5 younger patients completed the NPV-J. Preoperative scores for neuroticism, social anxiety, and dominance are therefore available for 8 patients. There was no consistency in low or high scoring for neuroticism or social anxiety, nor was there any consistent change (fig. [4a, b](#F4){ref-type="fig"}). There was however a change for dominance. Preoperatively, 5/7 subjects scored below average, but all subjects had increased scores at the latest follow-up (2/7 average, 5 above, fig. [4c](#F4){ref-type="fig"}, BL vs. END p \< 0.05).

Discussion {#sec1_4}
==========

LAGB led to successful weight loss (\>50s% excess weight reduction) in 6 out of 10 patients after a median follow-up of 64 months. The length of follow-up in this study was crucial. Most weight loss was not achieved in the first postoperative year but after that. The first band desufflation was done after 2 years, while after 3.5 years the first gastric band was removed. So had we studied this group after 2 or 3 years, the results would have been very different. Comorbidity before surgery, which was mostly limited to musculoskeletal and asthmatic complaints, showed resolution or improvement in most patients. There was 1 patient with adequate weight loss in whom the band was removed because of adverse effects. This patient remained at a stable -- healthy -- weight while studies in adults have shown that band removal is strongly associated with rapid weight regain \[[@B18]\]. We hypothesize that in this young individual restrictive bariatric surgery may have led to a permanently adjusted lifestyle and behavior towards food, since it is generally accepted that behavior changes are easier at younger age. Two patients in whom inadequate weight loss was achieved with LAGB successfully lost weight after conversion to a malabsorptive procedure. These procedures were however associated with more severe adverse effects, including two corrective procedures for internal hernia, a serious complication known to be associated with RYGB \[[@B19]\].

The reported physical and mental health status after LAGB is well within the Dutch population norms in 5 out of 7 patients. The 2 patients who perceived low mental and physical health status had successful weight loss and reported to be satisfied with their gastric band. However, one is struggling with body image and applied for corrective surgery, and the other was recently released from prison, which probably influences wellbeing more than the results of gastric banding.

Since bariatric surgery in adolescents was very exceptional at that time, and still is in the Netherlands, only a small group of patients could be included. There were no significant changes in eating behavior after LAGB. However, even in this small group, weight concern showed a decreasing trend. An interesting observation is the significant shift from a low dominant personality score to a higher score for all patients. The items involved in dominance relate to taking initiative, leadership, and confidence in a group. A low score on hostility, a scale reflecting criticism to others and distrust, seemed to be in line. However, low scores were also observed for self-esteem. Overall, the scores on the NPV reflected gained trust in positioning oneself towards others and feeling confident in contact with others, while still having a relatively low self-image. Whether this change was attributable to weight loss, aging or both cannot be concluded without a control group.

Despite well-organized preoperative evaluation and postoperative follow-up, there is missing data due to poor reporting and 30s% loss to follow-up in the past year. Still, follow-up in this study is longer than the vast majority of the available literature. A recent review found only one long-term retrospective LAGB study with more than 36 months follow-up in adolescents \[[@B6]\]. Meta-analysis of all eligible studies showed a BMI reduction of 11.6 kg/m^2^ while the long-term study by Silberhumer et al. \[[@B20]\] showed BMI loss of 18.1 kg/m^2^ (93s% excess weight loss) after 60 months follow-up. They showed that most of the weight loss occurred in the first 3 years while most complications occurred afterwards, which is in line with what was found in the present study.

Gastric banding is losing popularity in adults compared to sleeve gastrectomy and RYGB as the bariatric procedure of choice, but it carries definite advantages. It is the procedure with the lowest operative risk, and it is effective in the majority of patients. It does not alter gastrointestinal anatomy and is completely reversible. When weight loss is unsuccessful, a malabsorptive procedure as a second step seems a feasible and effective option for those who failed.

Conclusion {#sec1_5}
==========

LAGB in morbidly obese adolescents had a primary failure rate of 40s% after long-term follow-up, but was a successful therapy in the other 60s% without major adverse events. Conversion to malabsorptive procedures after unsuccessful weight loss was effective but associated with complications related to their invasiveness. We strongly encourage studies to continue follow-up for at least 5 years and to look at both weight loss and complications with the gastric band in situ and after conversion to more invasive procedures. Larger prospective studies should provide more insight in changed eating behavior and personality.
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![Subscale scores on the SF-36 quality of life questionnaire at the end of follow-up. Median values are presented in the dotted boxes. The red dotted bars indicate the Dutch population mean. The blue dashed bars indicate one standard deviation below mean. PF = Physical functioning; RP = role physical; BP = bodily pain; GH = general health; VT = vitality; SF = social functioning; RE = role emotional; MH = mental health.](ofa-0009-0344-g02){#F2}

![Subscale scores on the EDE-Q and NVE. Baseline (BL) scores are compared to end of follow-up, with or without gastric band in situ (END). The red dotted bars indicate the Dutch population mean. The blue dashed bars indicate one standard deviation above or below the mean.](ofa-0009-0344-g03){#F3}

![Neuroticism, social anxiety and dominance as scored on the NPV and/or NPV-J before surgery (BL) and at the last follow-up visit, with or without gastric band in situ (END). \*END versus BL p.](ofa-0009-0344-g04){#F4}

###### 

Baseline characteristics, weight loss, adverse events and (re)operations

  PID   Sex   Age, years   BMI, kg/m^2^   s%EBMIL   Follow-up, months   Adverse events (therapy)   Operation (BMI at total[\*\*](#T1F2){ref-type="table-fn"} FU)                                                                                                                                                       
  ----- ----- ------------ -------------- --------- ------------------- -------------------------- --------------------------------------------------------------- ----- ----- --------------------------------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------
  1     M     15.3         38.0           34.6      33.9                27.6                       82.1                                                            104   104   --                                                                                                                                      mammoplasty; revision mammoplasty
                                                                                                                                                                                                                                                                                                                       
  2     M     18.5         48.6           47.8      49.0                34.8                       58.7                                                            119   119   --                                                                                                                                      --
                                                                                                                                                                                                                                                                                                                       
  3     F     17.9         41.6           37.7      32.9                30.2                       68.6                                                            77    77    --                                                                                                                                      tonsillectomy
                                                                                                                                                                                                                                                                                                                       
  4     M     16.9         46.2           45.1      42.4                45.3                       6.8                                                             59    59    --                                                                                                                                      --
                                                                                                                                                                                                                                                                                                                       
  5     F     16.9         39.6           38.7      36.2                46.2                       −42.7                                                           41    85    referred shoulder pain (band removal); weight regain (BPD); intestinal inflammation (hospitalization); incisional hernia (correction)   BPD (22.9)
                                                                                                                                                                                                                                                                                                                       
  6     M     14.9         37.0           33.1      31.3                26.1                       91.7                                                            71    71    --                                                                                                                                      mammoplasty; ptosis correction
                                                                                                                                                                                                                                                                                                                       
  7     F     16.2         44.7           40.3      NA                  26.6                       92.3                                                            63    63                                                                                                                                            mammoplasty and lower body lift (complicated by hematoma)
                                                                                                                                                                                                                                                                                                                       
  8     F     16.7         43.0           34.4      NA                  30.5                       70.4                                                            55    73    persistent dyspnea (band removal)                                                                                                       band removal (34.0)
                                                                                                                                                                                                                                                                                                                       
  9     F     16.7         39.9           NA        NA                  34.1                       41.2                                                            44    73    obstruction (desufflation/re-insufflation); weight regain (RYGB); internal hernia after RYGB (repair and re-repair)                     RYGB (25.0)
                                                                                                                                                                                                                                                                                                                       
  10    F     14.7         51.0           NA        NA                  59.6                       −26.7                                                           64    64    slippage (desufflation / re-insufflation)                                                                                               band removal (59.6)

6M = 6 months; 12M = 12 months; BPD = biliopancreatic diversion; RYGB = Roux-en-Y gastric bypass; NA = not available.

End of follow-up with in situ gastric band.

End of follow-up after re-operation (when applicable).

###### 

Comorbidity

                                                  Pre-operative   End of follow-up                      
  ----------------------------------------------- --------------- ------------------ --- ---- ---- ---- ----
  Hypertension[^a^](#T2F1){ref-type="table-fn"}   2               8                  0   2    --   --   --
  T2DM[^b^](#T2F2){ref-type="table-fn"}           0               10                 0   --   --   --   --
  Dyslipidemia[^c^](#T2F3){ref-type="table-fn"}   0               7                  3   --   --   --   --
  Musculoskeletal complaints                      10              0                  0   4    1    2    3
  Asthma / dyspnea                                7               2                  1   1    4    --   2

NR = not reported.

Hypertension: diastolic \> 140 mm Hg or systolic \> 90 mm Hg.

Dyslipidemia: total cholesterol \> 6.4 mmol/l, HDL cholesterol \< 0.9 mmol/l, LDL cholesterol \> 4.4 mmol/l or triglycerides \> 1.94 mmol/l.

T2DM: HbA1C \> 6.25 or \> 44 mmol/mol Hb, fasted glucose \> 7.0 mmol/l.
